Filter your results
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 4
- 4
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.BJC, 2012, 106 (3), pp.460-7. ⟨10.1038/bjc.2011.557⟩
Journal articles
inserm-00799502v1
|
||
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study.Anti-Cancer Drugs, 2010, 21 (3), pp.320-5. ⟨10.1097/CAD.0b013e328334d953⟩
Journal articles
inserm-00484315v1
|
|||
|
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer.World Journal of Surgical Oncology, 2009, 7, pp.14. ⟨10.1186/1477-7819-7-14⟩
Journal articles
inserm-00484421v1
|
||
Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.Cancer Chemotherapy and Pharmacology, 2008, 61 (3), pp.415-21. ⟨10.1007/s00280-007-0484-x⟩
Journal articles
istex
inserm-00483417v1
|